New biodegradable stents offer hope for PSC patients
NCT ID NCT07607353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether biodegradable stents can safely open narrowed bile ducts in 20 people with primary sclerosing cholangitis (PSC). The stents are placed during an endoscopic procedure and dissolve over time, aiming to improve symptoms like itching and fatigue and prevent the stricture from coming back within a year. Participants must have a high-grade stricture and no recent stent or balloon treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS (PSC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King's College Hospital, London
RECRUITINGLondon, SE5 9RS, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One pill may tame both itchy skin and stubborn liver disease
- Could a common antibiotic ease Kids' bowel disease?
- Poop pills could tame rare liver disease
- Old antibiotic, new hope? vancomycin trial for UC and PSC
- New drug LB-P8 aims to tame rare liver disease PSC
- New pill shows promise for rare liver disease